Literature DB >> 1436417

Monitoring of brain tissue pressure with a fiberoptic device.

G Gambardella1, D d'Avella, F Tomasello.   

Abstract

Continuous monitoring of brain tissue pressure can now be achieved with intracerebral placement of fiberoptic microtransducers. This study was undertaken to test the safety, accuracy, and reliability of this relatively new type of intracranial pressure (ICP) monitoring. Initially, the fiberoptic device was compared with a concurrently functioning intraventricular catheter in 18 patients. The results from the two methods corresponded closely over a wide range of pressures, and the correlation coefficient approached 1.0. Subsequently, this monitor was used for routine measurement of ICP in a series of almost 200 neurosurgical patients at risk of intracranial hypertension. The tracings showed good wave forms and consistent absolute values of ICP. No instances of hemorrhage, mechanical failure, or other complications were associated with this monitor, except one case of infection, which was not directly attributable to the device per se. When bilateral intraparenchymal pressures were recorded in patients with unilateral mass lesions, significant transitory pressure differentials between the ipsilateral and contralateral sides were documented. It is concluded that monitoring intraparenchymal pressure with the fiberoptic device offers safe and reliable ICP recordings for routine neurosurgical practice. In patients with unilateral masses, ICP should be measured in close proximity to the lesion.

Entities:  

Mesh:

Year:  1992        PMID: 1436417     DOI: 10.1227/00006123-199211000-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

1.  Complications of brain tissue pressure monitoring with a fiberoptic device.

Authors:  A Bekar; S Gören; E Korfali; K Aksoy; S Boyaci
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

2.  Evaluation of minimally invasive percutaneous CT-controlled ventriculostomy in patients with severe head trauma.

Authors:  M Krötz; U Linsenmaier; K G Kanz; K J Pfeifer; W Mutschler; M Reiser
Journal:  Eur Radiol       Date:  2003-11-06       Impact factor: 5.315

3.  Differentiate the Source and Site of Intracranial Pressure Measurements Using More Precise Nomenclature.

Authors:  DaiWai M Olson; Stefany Ortega Peréz; Jonathan Ramsay; Chethan P Venkatasubba Rao; Jose I Suarez; Molly McNett; Venkatesh Aiyagari
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

4.  Intracranial pressure-monitoring systems in children with traumatic brain injury: combining therapeutic and diagnostic tools.

Authors:  Jennifer Exo; Patrick M Kochanek; P David Adelson; Stephanie Greene; Robert S B Clark; Hülya Bayir; Stephen R Wisniewski; Michael J Bell
Journal:  Pediatr Crit Care Med       Date:  2011-09       Impact factor: 3.624

5.  Measurement of Hip Contact Pressure During Arthroscopic Femoroacetabular Impingement Surgery.

Authors:  Mitsunori Kaya
Journal:  Arthrosc Tech       Date:  2017-05-01

6.  The baseline pressure of intracranial pressure (ICP) sensors can be altered by electrostatic discharges.

Authors:  Per K Eide; André Bakken
Journal:  Biomed Eng Online       Date:  2011-08-22       Impact factor: 2.819

7.  Regional pressure and temperature variations across the injured human brain: comparisons between paired intraparenchymal and ventricular measurements.

Authors:  Charmaine Childs; Liang Shen
Journal:  Crit Care       Date:  2015-06-23       Impact factor: 9.097

Review 8.  Advances in Intracranial Pressure Monitoring and Its Significance in Managing Traumatic Brain Injury.

Authors:  Usmah Kawoos; Richard M McCarron; Charles R Auker; Mikulas Chavko
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

Review 9.  Accuracy of intracranial pressure monitoring: systematic review and meta-analysis.

Authors:  Lucia Zacchetti; Sandra Magnoni; Federica Di Corte; Elisa R Zanier; Nino Stocchetti
Journal:  Crit Care       Date:  2015-12-02       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.